{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:41:54Z","timestamp":1755693714873,"version":"3.41.0"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1001\/jamapsychiatry.2018.0101","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T16:31:35Z","timestamp":1524673895000},"page":"642","source":"Crossref","is-referenced-by-count":3,"title":["Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury"],"prefix":"10.1001","volume":"75","author":[{"given":"Thomas R.","family":"Kosten","sequence":"first","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas"},{"name":"Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Graham","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas"},{"name":"Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas"},{"name":"Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"journal-title":"JAMA Psych","article-title":"Opioid use disorder after self-medicating pain from traumatic brain injury [published online April 25, 2018].","author":"Kosten","key":"yrv180001r1"},{"issue":"3","key":"yrv180001r2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury.","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol"},{"issue":"16","key":"yrv180001r3","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin.","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"yrv180001r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"6","key":"yrv180001r5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior.","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"2","key":"yrv180001r6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway.","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"3","key":"yrv180001r7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1124\/pr.110.004135","article-title":"Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.","volume":"63","author":"Hutchinson","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"1","key":"yrv180001r8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00726-011-1163-0","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function.","volume":"45","author":"Ninkovic","year":"2013","journal-title":"Amino Acids"},{"issue":"1","key":"yrv180001r9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0022-3565(24)29295-8","article-title":"Mechanisms of induction of persistent nociception by dynorphin.","volume":"299","author":"Laughlin","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"yrv180001r10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.peptides.2017.02.004","article-title":"Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signaling pathway.","volume":"90","author":"Rahiman","year":"2017","journal-title":"Peptides"},{"key":"yrv180001r11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species.","volume":"5","author":"Vaure","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"yrv180001r14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nec.2016.06.002","article-title":"Pathophysiology of traumatic brain injury.","volume":"27","author":"McGinn","year":"2016","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"yrv180001r15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00005072-198305000-00002","article-title":"Axonal change in minor head injury.","volume":"42","author":"Povlishock","year":"1983","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"yrv180001r16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00005072-199904000-00007","article-title":"The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury.","volume":"58","author":"B\u00fcki","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"yrv180001r17","first-page":"181","article-title":"All roads lead to disconnection?: traumatic axonal injury revisited.","volume":"148","author":"B\u00fcki","year":"2006"},{"issue":"5","key":"yrv180001r18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/neu.2012.2825","article-title":"Therapy development for diffuse axonal injury.","volume":"30","author":"Smith","year":"2013","journal-title":"J Neurotrauma"},{"issue":"8","key":"yrv180001r19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/NEN.0b013e31829d8d9d","article-title":"Diffuse traumatic axonal injury in the optic nerve does not elicit retinal ganglion cell loss.","volume":"72","author":"Wang","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"yrv180001r20","first-page":"465","article-title":"Massive astrocytic swelling in response to extracellular glutamate\u2013a possible mechanism for post-traumatic brain swelling?","volume":"60","author":"Maxwell","year":"1994","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"yrv180001r21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0079-6123(06)61010-8","article-title":"Injury-induced alterations in CNS electrophysiology.","volume":"161","author":"Cohen","year":"2007","journal-title":"Prog Brain Res"},{"key":"yrv180001r22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death.","volume":"3","author":"Rock","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"yrv180001r23","first-page":"428","article-title":"Focal brain injury: histological evidence of delayed inflammatory response in a new rodent model of focal cortical injury.","volume":"60","author":"Mathew","year":"1994","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"1","key":"yrv180001r24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1568006043481284","article-title":"Microglia: neuroprotective and neurotrophic cells in the central nervous system.","volume":"4","author":"Nakajima","year":"2004","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"issue":"3-4","key":"yrv180001r25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1359-6101(98)00015-X","article-title":"Cytokine actions in the central nervous system.","volume":"9","author":"Benveniste","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"yrv180001r26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-8993(87)90505-1","article-title":"Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.","volume":"425","author":"McIntosh","year":"1987","journal-title":"Brain Res"},{"issue":"5 Pt 1","key":"yrv180001r27","first-page":"E565","article-title":"Endogenous opioids may mediate secondary damage after experimental brain injury.","volume":"253","author":"McIntosh","year":"1987","journal-title":"Am J Physiol"},{"issue":"4","key":"yrv180001r28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/neu.1993.10.373","article-title":"Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.","volume":"10","author":"McIntosh","year":"1993","journal-title":"J Neurotrauma"},{"issue":"1","key":"yrv180001r29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0006-8993(94)90834-6","article-title":"The role of opioids in newborn pig fluid percussion brain injury.","volume":"660","author":"Armstead","year":"1994","journal-title":"Brain Res"},{"issue":"6","key":"yrv180001r30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1176\/ajp.144.6.813","article-title":"Naltrexone treatment for postconcussional syndrome.","volume":"144","author":"Tennant","year":"1987","journal-title":"Am J Psychiatry"},{"issue":"12","key":"yrv180001r31","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1021\/acs.jmedchem.5b00426","article-title":"Structure-activity relationships of (+)-naltrexone-inspired toll-like receptor 4 (tlr4) antagonists.","volume":"58","author":"Selfridge","year":"2015","journal-title":"J Med Chem"},{"issue":"5","key":"yrv180001r32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","article-title":"(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.","volume":"13","author":"Lewis","year":"2012","journal-title":"J Pain"},{"issue":"10","key":"yrv180001r33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/026990500445745","article-title":"Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury.","volume":"14","author":"Calvanio","year":"2000","journal-title":"Brain Inj"},{"issue":"11","key":"yrv180001r34","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"issue":"3","key":"yrv180001r35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pharmthera.2008.11.005","article-title":"Physiological and pharmacological implications of beta-arrestin regulation.","volume":"121","author":"Schmid","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"4","key":"yrv180001r36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00005053-199004000-00001","article-title":"Neurobiology of abused drugs: opioids and stimulants.","volume":"178","author":"Kosten","year":"1990","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"yrv180001r37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","article-title":"Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.","volume":"53","author":"Ferguson","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"30","key":"yrv180001r38","doi-asserted-by":"publisher","first-page":"27770","DOI":"10.1074\/jbc.M102264200","article-title":"Identification of a motif in the carboxyl terminus of beta-arrestin2 responsible for activation of JNK3.","volume":"276","author":"Miller","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"yrv180001r39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1124\/mol.112.083279","article-title":"Recent developments in the study of opioid receptors.","volume":"83","author":"Cox","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"5","key":"yrv180001r40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/00000542-199505000-00018","article-title":"The effect of intrinsic efficacy on opioid tolerance.","volume":"82","author":"Duttaroy","year":"1995","journal-title":"Anesthesiology"},{"issue":"4","key":"yrv180001r41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/ppr.2008.8.issue-4","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"issue":"1","key":"yrv180001r42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/mol.109.060848","article-title":"mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD.","volume":"77","author":"Zheng","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"4","key":"yrv180001r43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0896-6273(01)80032-5","article-title":"Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.","volume":"23","author":"Whistler","year":"1999","journal-title":"Neuron"},{"issue":"10","key":"yrv180001r44","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.cellsig.2014.06.016","article-title":"Homo- and hetero-oligomerization of \u00df2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology.","volume":"26","author":"Wnorowski","year":"2014","journal-title":"Cell Signal"},{"key":"yrv180001r45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuropharm.2015.08.010","article-title":"Dual allosteric modulation of opioid antinociceptive potency by a2A-adrenoceptors.","volume":"99","author":"Chabot-Dor\u00e9","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"yrv180001r46","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"Beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor.","volume":"281","author":"Shenoy","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"yrv180001r47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bph.2015.172.issue-2","article-title":"Analgesic synergy between opioid and a2-adrenoceptors.","volume":"172","author":"Chabot-Dor\u00e9","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"1-3","key":"yrv180001r48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neulet.2003.12.065","article-title":"Alpha-2-adrenergic and opioid receptor additivity in rat locus coeruleus neurons.","volume":"361","author":"Stone","year":"2004","journal-title":"Neurosci Lett"},{"issue":"11","key":"yrv180001r49","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrd1875","article-title":"New concepts in drug discovery: collateral efficacy and permissive antagonism.","volume":"4","author":"Kenakin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"yrv180001r50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tips.2007.06.009","article-title":"Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.","volume":"28","author":"Kenakin","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"yrv180001r51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact.","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"yrv180001r52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology.","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"yrv180001r53","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1074\/jbc.M806742200","article-title":"p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons.","volume":"284","author":"Tan","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"yrv180001r54","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-3565(24)37884-X","article-title":"Spinal morphine\/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase A activity.","volume":"287","author":"Wei","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"yrv180001r55","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1111\/bph.v174.16","article-title":"Characterization of functional \u00b5 opioid receptor turnover in rat locus coeruleus: an electrophysiological and immunocytochemical study.","volume":"174","author":"Medrano","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"1","key":"yrv180001r56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u00b5-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"3","key":"yrv180001r57","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1213\/01.ANE.0000160588.32007.AD","article-title":"The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance.","volume":"101","author":"Zuo","year":"2005","journal-title":"Anesth Analg"},{"issue":"5","key":"yrv180001r58","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.conb.2007.10.004","article-title":"The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.","volume":"17","author":"Martini","year":"2007","journal-title":"Curr Opin Neurobiol"},{"issue":"9","key":"yrv180001r59","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/npp.2009.34","article-title":"Bidirectional effects of fentanyl on dendritic spines and AMPA receptors depend upon the internalization of mu opioid receptors.","volume":"34","author":"Lin","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"yrv180001r60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jama.279.3.229","article-title":"Rapid and ultrarapid opioid detoxification techniques.","volume":"279","author":"O\u2019Connor","year":"1998","journal-title":"JAMA"},{"issue":"18","key":"yrv180001r61","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra020617","article-title":"Management of drug and alcohol withdrawal.","volume":"348","author":"Kosten","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"yrv180001r62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1300\/J069v25n04_03","article-title":"Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.","volume":"25","author":"Davison","year":"2006","journal-title":"J Addict Dis"},{"issue":"10","key":"yrv180001r63","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4088\/JCP.09m05080ecr","article-title":"Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment.","volume":"71","author":"Brooks","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"yrv180001r64","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"Mu opioid receptor gene variants: lack of association with alcohol dependence.","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol Psychiatry"},{"issue":"16","key":"yrv180001r65","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"yrv180001r66","doi-asserted-by":"publisher","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"yrv180001r67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-4159.2007.04738.x","article-title":"The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.","volume":"103","author":"Kroslak","year":"2007","journal-title":"J Neurochem"},{"issue":"5","key":"yrv180001r68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF03256337","article-title":"Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery.","volume":"13","author":"Wu","year":"2009","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"yrv180001r69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(ISSN)1096-8628","article-title":"Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).","volume":"118B","author":"Hernandez-Avila","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"yrv180001r70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade.","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"yrv180001r71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept.","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"46","key":"yrv180001r72","doi-asserted-by":"publisher","first-page":"45978","DOI":"10.1074\/jbc.M304504200","article-title":"A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors.","volume":"278","author":"Tanowitz","year":"2003","journal-title":"J Biol Chem"},{"issue":"23","key":"yrv180001r73","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/0024-3205(95)02204-V","article-title":"Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding.","volume":"57","author":"Zernig","year":"1995","journal-title":"Life Sci"},{"issue":"3","key":"yrv180001r74","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00952990.2011.653426","article-title":"Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.","volume":"38","author":"Sigmon","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"yrv180001r12","first-page":"22","volume-title":"Textbook of Traumatic Brain Injury","author":"Smith","year":"2011","edition":"2nd ed"},{"key":"yrv180001r13","unstructured":"Centers for Disease Control and Prevention, National Institutes of Health, Department of Defense, Department of Veterans Affairs. Report to Congress on Traumatic Brain Injury in the United States: Understanding the Public Health Problem Among Current and Former Military Personnel. https:\/\/www.cdc.gov\/traumaticbraininjury\/pdf\/report_to_congress_on_traumatic_brain_injury_2013-a.pdf. Accessed March 12, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2678578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T23:02:10Z","timestamp":1751583730000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.0101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.0101","relation":{},"ISSN":["2168-622X"],"issn-type":[{"type":"print","value":"2168-622X"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}